332.89999 EUR
3.9
1.16%
Last update Dec 15, 9:57 PM CET
Main market
Day range
332.10001
345
Previous close
336.79999
Open
337.5
Access this stock data via API
Subscribe
Alnylam Pharmaceuticals Inc.
332.90
3.90
1.16%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 1.9B 1.8B 1.0B 844.3M
Cost of revenue 275.6M 310.4M 168.8M 140.1M
Gross profit 1.6B 1.5B 868.6M 704.1M
Operating expense
Research & development 959.8M 1.0B 883.0M 792.2M
Selling general and admin 831.4M 795.6M 770.7M 620.6M
Other operating expenses
Operating income -150.8M -282.2M -785.1M -708.7M
Non operating interest income
Income 104.0M 95.6M 24.8M 1.6M
Expense 120.9M 121.2M 156.0M 143.0M
Other income expense -153.9M -125.7M -210.8M -2.1M
Pretax income -321.6M -433.5M -1.1B -852.1M
Tax provision -84.6M 6.7M 4.2M 680K
Net income -237.1M -440.2M -1.1B -852.8M
Basic EPS -2.2 -3.5 -9.3 -7.2
Diluted EPS -2.2 -3.5 -9.3 -7.2
Basic average shares 108.8M 130.3M 124.9M 121.6M
Diluted average shares 108.8M 130.3M 124.9M 121.6M
EBITDA -4.3M -107.3M -680.9M -636.7M
Net income from continuing op. -237.1M -440.2M -1.1B -852.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 7 hours

14:59
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).